Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B

<p>1. Harnessing the immune system: Insights into cancer vaccines </p><p>Sushree Subhadra Acharya, Subhasmita Bhal, Biswajit Das, and </p><p>Chanakya Nath Kundu </p> <p>2. Lipid nanoparticle mediated mRNA delivery in cancer immunotherapy </p><p>Gyati Shilakari Asthana, Saptarshee Bhattacharjee, Jitendra Kumar, Soyal Sayyed, Amulya Jindal, Pankaj Kumar, Abhijeet Chinchane, Atreyee Bhattacharyya, Roshani Jaiswal, </p><p>Sagar Kulkarni, Shubham Gajdhane, Jitender Madan, and Abhay Asthana </p> <p>3. Nanoparticles for mRNA-based cancer immunotherapy </p><p>Rakesh Pahwa, Gulshan Sharma, Rohil Panwar, and Neeraj Mishra </p> <p>4. B-cell editing: An emerging alternative of precision oncotherapy </p><p>Pritha Roy Choudhury, Mohona Chakravarti, Saptak Banerjee, </p><p>Rathindranath Baral, and Anamika Bose </p> <p>5. Personalized precision: Revolutionizing cancer treatment with mRNA-based vaccines in melanoma therapy </p><p>Krishnendu Adhikary, Abhik Paul, Ayush Madan, Anas Islam, Sumel Ashique, <br>and Mohhammad Ramzan </p> <p>6. Revolutionizing cancer treatment: Exploring novel immunotherapeutics, checkpoints, bispecifics, and vaccines in development </p><p>Anas Islam, Vijay Singh, Pooja S. Murkute, Sumel Ashique, </p><p>Shriyansh Srivastava, Mohammad Yousuf Ansari, and Sabina Yasmin </p> <p>7. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA & mRNA vaccine in cancer immunotherapy </p><p>Monika Kaushik, Prathap Madeswaraguptha, Murugesan Vanangamudi, Vijayaraj Surendran, Sumel Ashique, Anas Islam, Naheed Mojgani, and Afzal Hussain </p>